Ginkgo Bioworks Holdings, Inc.
DNANYSEHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $730.23M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $5.37$18.22
- Volume (live)
- -
- Avg. volume (3M)
- 2.91M
Ginkgo Bioworks Holdings (DNA) Stock Price & Financial Analysis
Ginkgo Bioworks Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.13 - $11.80 |
|---|---|
| 52-Week High | $18.22 |
| 52-Week Low | $5.37 |
| Open | $11.62 |
| Volume (last close) | 3.55M |
| Average Volume (3M) | 2.91M |
| Revenue (TTM) | 111.86M |
|---|---|
| Net Income (TTM) | -290.80M |
| Free Cash Flow (TTM) | -190.12M |
| EPS (TTM) | −$4.96 |
| Profit Margin | -259.96% |
| Operating Margin | -259.23% |
| Return on Equity (ROE) | -69.19% |
| Debt to Equity | 0.96 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 730.23M |
|---|---|
| Shares Outstanding | 62.09M |
| Price to Sales (P/S) | 6.53 |
| Price to Book (P/B) | 1.74 |
| EV/EBITDA | -4.28 |
| 50-Day MA | $8.75 |
|---|---|
| 200-Day MA | $8.48 |
| 1-Year Change | −11.25% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Ginkgo Bioworks Holdings at a Glance
As of the Oct 16, 2026 close, Ginkgo Bioworks Holdings (DNA) has a market capitalization of $730.23M. The stock trades at 6.5× sales. Over the trailing twelve months it lost $290.80M on revenue of $111.86M and burned $190.12M of free cash flow. Revenue fell 49.3% year over year.
As of its latest reported balance sheet, it holds $84.53M in cash and securities against $404.11M of debt, a net debt position of $319.58M.
Ginkgo Bioworks Holdings does not currently pay a dividend.
The share price is down 11.2% over the past year. At $10.27 (the Oct 16, 2026 close) it sits within its 52-week range of $5.37 to $18.22, above its 200-day moving average of $8.48.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Ginkgo Bioworks Holdings
What is the current stock price for DNA?
As of the Oct 16, 2026 close, DNA stock trades at $10.27. The 52-week range is $5.37–$18.22, with a day range of $10.13–$11.80.
What is the P/E ratio for DNA?
The P/E ratio (Price-to-Earnings) for DNA is shown in the Key Statistics section. This valuation metric helps compare Ginkgo Bioworks Holdings, Inc. to industry peers.
Does DNA pay dividends?
Ginkgo Bioworks Holdings does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for DNA?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for DNA is Hold.
What is the market cap of DNA?
As of the Oct 16, 2026 close, Ginkgo Bioworks Holdings's market capitalization is $637.7M, classifying it as a small-cap company. Ginkgo Bioworks Holdings operates in the Healthcare sector within the Biotechnology industry.